Ed Casson

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

Stephen Daniels, Ed Casson, Jens‐Ulrich Stegmann et al. · Current Medical Research and Opinion · 2009 · 131 citations

A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK

Emma Dean, Udai Banerji, Jan H.M. Schellens et al. · Cancer Chemotherapy and Pharmacology · 2018 · 25 citations · Full text

161O VIOLETTE: Randomised phase II study of olaparib (ola) + ceralasertib (cer) or adavosertib (ada) vs ola alone in patients (pts) with metastatic triple-negative breast cancer (mTNBC)

Andrew Tutt, Zbigniew Nowecki, R. Szoszkiewicz et al. · Annals of Oncology · 2022 · 19 citations